Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

65096510651165126513651465156516651765186519652065216522652365246525652665276528652965306531653265336534653565366537653865396540654165426543654465456546654765486549655065516552655365546555655665576558655965606561as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J ClinOncol. 2010 Nov 1;28(31):4697-705. doi: 10.1200/JCO.2009.27.4860. Epub 2010 Oct 4.Dube S, Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis. DisColon Rectum. 1997;40(1):35-41.Ducreux M, Adenis A, Pignon JP et al. Efficacy and safety of bevacizumab-based combination regimens inpatients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study ofbevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan(FNCLCC ACCORD 13/0503 study). Eur J Cancer 2013;Jan 24 Epub ahead of printDuncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP. Embolization of portal vein branches induces hepatocytereplication in swine: a potential step in hepatic gene therapy.Radiology 1999;210:467-477.Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P. Results of 136 curative hepatectomies witha safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998; 69:88-93.Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: the real impact ofthe surgical margin. Eur J Surg Oncol 1998;24:174-179.Elias D, de Baere T, Roche A, Mducreux, Leclere J, Lasser P. During liver regeneration following right portalembolization the growth rate of liver metastases is more rapid than that of the liver parenchyma.Br J Surg 1999;86:784-788Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicatehepatectomy for colorectal liver metastases.Br J Surg 2003;90:567-574.Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol BiolPhys 1991 May 15;21(1):109-22.Endreseth BH, Myrvold HE, Romundstad P et al. Transanal excision vs. major surgery for T1 rectal cancer. DisColon Rectum 2005; 48:1380-8.Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003; 90:272-289.Evidence-based Richtlijnontwikkeling Handleiding voor werkgroepleden Kwaliteitsinstituut voor deGezondheidszorg CBO, april 2005.Facey F, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomographyimaging in selected cancers. Health Technol Assess 2007;11(44):iii-85.Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA et al. Positron emission tomography forpreoperative staging of colorectal carcinoma. Dis.Colon Rectum 1994;37(2):153-6.Feingold DL, Addona T, Forde KA, Arnell TD, Carter JJ, Huang EH, Whelan RL. Safety and reliability of tattooingcolorectal neoplasms prior to laparoscopic resection. J Gastrointest Surg. 2004 Jul-Aug;8(5):543-6.Figer A, Perez-Staub N, Carola E, et al. FOLFOX in patients aged between 76 and 80 years with metastaticcolorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 2007;110:2666-71.Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperativechemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001; 88:980-985.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 156